- Home
- VYNE vs MNDO Comparison
VYNE vs MNDO Comparison
Compare VYNE & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- MNDO
- Stock Information
- Founded
- VYNE 2003
- MNDO 1995
- Country
- VYNE United States
- MNDO Israel
- Employees
- VYNE N/A
- MNDO N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- MNDO EDP Services
- Sector
- VYNE Health Care
- MNDO Technology
- Exchange
- VYNE Nasdaq
- MNDO Nasdaq
- Market Cap
- VYNE 35.7M
- MNDO 34.2M
- IPO Year
- VYNE 2018
- MNDO 2000
- Fundamental
- Price
- VYNE $1.30
- MNDO $1.39
- Analyst Decision
- VYNE Strong Buy
- MNDO
- Analyst Count
- VYNE 2
- MNDO 0
- Target Price
- VYNE $6.25
- MNDO N/A
- AVG Volume (30 Days)
- VYNE 222.4K
- MNDO 52.2K
- Earning Date
- VYNE 05-08-2025
- MNDO 05-06-2025
- Dividend Yield
- VYNE N/A
- MNDO 15.88%
- EPS Growth
- VYNE N/A
- MNDO N/A
- EPS
- VYNE N/A
- MNDO 0.17
- Revenue
- VYNE $605,000.00
- MNDO $20,677,000.00
- Revenue This Year
- VYNE N/A
- MNDO N/A
- Revenue Next Year
- VYNE N/A
- MNDO N/A
- P/E Ratio
- VYNE N/A
- MNDO $8.14
- Revenue Growth
- VYNE 43.03
- MNDO N/A
- 52 Week Low
- VYNE $1.27
- MNDO $1.43
- 52 Week High
- VYNE $4.30
- MNDO $2.13
- Technical
- Relative Strength Index (RSI)
- VYNE 34.90
- MNDO 16.01
- Support Level
- VYNE $1.27
- MNDO $1.66
- Resistance Level
- VYNE $1.41
- MNDO $1.69
- Average True Range (ATR)
- VYNE 0.12
- MNDO 0.04
- MACD
- VYNE -0.01
- MNDO -0.02
- Stochastic Oscillator
- VYNE 5.46
- MNDO 12.86
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.